Active	Status	Sponsor type	Region	Phase	Filter
5 Active 6 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
COVAX-19 (GC004) / Flinders University, Vaxine, GeneCure Biotechnologies, Medytox, CinnaGen
NCT05279456: A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)	Active, not recruiting	3	39	RoW	Advax-CpG55.2 adjuvanted recombinant spike protein, Spikogen vaccine	Vaxine Pty Ltd, Australian Respiratory and Sleep Medicine Institute	COVID-19	12/23	10/24
NCT05542862: Booster Study of SpikoGen COVID-19 Vaccine	Active, not recruiting	3	150	RoW	SpikoGen vaccine, Covax-19	Vaxine Pty Ltd, Australian Respiratory and Sleep Medicine Institute Ltd, Cinnagen	COVID-19	12/23	10/24
NCT05148871: Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine	Active, not recruiting	2/3	200	RoW	Spikogen/Covax-19	Vaxine Pty Ltd, Australian Respiratory and Sleep Medicine Institute, Cinnagen	COVID-19	02/23	10/24
NCT05285384: Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine	Completed	N/A	43	RoW	SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, SpikoGen, COVAX-19	Cinnagen, Shahid Beheshti University of Medical Sciences, Vaxine Pty Ltd	COVID-19	03/22	03/22
Hepadvax (hepatitis B vaccine) / Vaxine
HBV003, NCT03038802: A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection	Not yet recruiting	1/2	40	RoW	Therapeutic hepatitis B vaccine, Hepadvax(TM), Commercial Hepatitis B vaccine, Engerix B	Vaxine Pty Ltd, Australian Respiratory and Sleep Medicine Institute	Chronic Hepatitis b	12/25	12/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
COVAX-19 (GC004) / Flinders University, Vaxine, GeneCure Biotechnologies, Medytox, CinnaGen
NCT05279456: A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)	Active, not recruiting	3	39	RoW	Advax-CpG55.2 adjuvanted recombinant spike protein, Spikogen vaccine	Vaxine Pty Ltd, Australian Respiratory and Sleep Medicine Institute	COVID-19	12/23	10/24
NCT05542862: Booster Study of SpikoGen COVID-19 Vaccine	Active, not recruiting	3	150	RoW	SpikoGen vaccine, Covax-19	Vaxine Pty Ltd, Australian Respiratory and Sleep Medicine Institute Ltd, Cinnagen	COVID-19	12/23	10/24
NCT05148871: Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine	Active, not recruiting	2/3	200	RoW	Spikogen/Covax-19	Vaxine Pty Ltd, Australian Respiratory and Sleep Medicine Institute, Cinnagen	COVID-19	02/23	10/24
NCT05285384: Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine	Completed	N/A	43	RoW	SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, SpikoGen, COVAX-19	Cinnagen, Shahid Beheshti University of Medical Sciences, Vaxine Pty Ltd	COVID-19	03/22	03/22
Hepadvax (hepatitis B vaccine) / Vaxine
HBV003, NCT03038802: A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection	Not yet recruiting	1/2	40	RoW	Therapeutic hepatitis B vaccine, Hepadvax(TM), Commercial Hepatitis B vaccine, Engerix B	Vaxine Pty Ltd, Australian Respiratory and Sleep Medicine Institute	Chronic Hepatitis b	12/25	12/26